Characterization of SOX2 expression in surgically resected brain tissues from GBM patients was next accomplished in the tumor, peritumoral, and adjacent normal-appearing regions that were defined by histopathology (Fig 7D1–7D3). The gene discussed is SOX2; the disease is glioblastoma.